Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2016, Article ID 8915047, 2 pages
http://dx.doi.org/10.1155/2016/8915047
Case Report

Rituximab-Associated Inflammatory Progressive Multifocal Leukoencephalopathy

Madigan Army Medical Center, Tacoma, WA, USA

Received 5 July 2016; Revised 14 September 2016; Accepted 20 October 2016

Academic Editor: Jean-François Faucher

Copyright © 2016 Chandra Punch et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. R. Carson, A. M. Evens, E. A. Richey et al., “Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project,” Blood, vol. 113, no. 20, pp. 4834–4840, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. D. B. Clifford, “Progressive multifocal leukoencephalopathy therapy,” Journal of NeuroVirology, vol. 21, no. 6, pp. 632–636, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. M. A. Lima, “Progressive multifocal leukoencephalopathy: new concepts,” Arquivos de Neuro-Psiquiatria, vol. 71, no. 9, pp. 699–702, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. P. S. Giacomini, A. Rozenberg, I. Metz, D. Araujo, N. Arbour, and A. Bar-Or, “Maraviroc and JC virus–associated immune reconstitution inflammatory syndrome,” The New England Journal of Medicine, vol. 370, no. 5, pp. 486–488, 2014. View at Publisher · View at Google Scholar · View at Scopus